Eko Company
.png)
Eko develops FDA approved, AI-powered heart sound and EKG sensors for heart disease monitoring.
Headquarters:
San Francisco Bay Area, West Coast, Western US
Last Funding Type:
Series C
Investors Number:
22
Last Funding Date:
2020
Employee Number:
11-50
Total Funding:
95500000
Founded Date:
2013-01-01
Technology:
Digital Healthcare
Estimated Revenue:
$1M to $10M
Investor Type:
Late Stage Venture
Industry:
Artificial Intelligence, Health Care, Health Diagnostics, Machine Learning, Medical Device, Software, mHealth
Funding Status:
Late Stage Venture